Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3879-3886

  Budai, B ^a   Szamel, I ^a   Sulyok, Z ^a   Nemeth, M ^a   Bak, M ^a   Kralovanszky, J ^a   Otto, Sz ^a   Besznyak, I ^a   Purohit, A ^a   Parish, D C ^a   Reed, M J ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Breast cyst fluid; Menstrual phase; Reproductive history; Steroid hormones

Indexed keywords

ESTRONE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTRACEPTION; FIBROCYSTIC BREAST DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; DEHYDROEPIANDROSTERONE; EXUDATES AND TRANSUDATES; FEMALE; FIBROCYSTIC BREAST DISEASE; FOLLICULAR PHASE; HUMANS; LACTATION; LUTEAL PHASE; MIDDLE AGED; POSTMENOPAUSE; POTASSIUM; PREMENOPAUSE; PROGESTERONE; REGRESSION ANALYSIS; RISK FACTORS; SODIUM; TESTOSTERONE;

EID: 0034529260     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Is cystic disease related to breast cancer?
2. Risk of breast cancer in women with palpable breast cysts: A prospective study
3. Steroid biochemistry and categorization of breast cyst fluid: Relation to breast cancer risk
4. Uptake and concentration of steroid hormones in mammary tissues
5. Treatment of menopause and cancer of the breast: Point of view of the hormonologist
6. The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas
7. Hormones and the pathophysiology of fibrocystic mastopathy: Elevated luteinizing hormone levels
8. Breast carcinoma etiological factors
9. Serum prolactin levels in women with gross cystic breast disease
10. Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia
11. Hormones and the pathophysiology of fibrocystic mastopathy
12. Natural killer cell activity and sex hormone levels in mastopathy
13. Steroid hormones in breast cyst fluids
14. Estrone-3-sulfate in human breast cyst fluid
15. Steroid patterns of benign breast disease
16. Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian wome
17. Gross cystic breast disease and breast cancer risk
18. Uptake of dehidroepiandrosterone-sulphate into human breast cyst fluid
19. Tumor markers in human breast cyst fluid
20. Biochemical classification of patients with gross cystic breast disease
21. Hormonal composition of breast cyst fluid and the menstrual status of patients
22. Plasma hormones in premenopausal women with benign breat disease
23. Levels of androgen conjugates and oestrone sulphate in patients with breast cysts
24. Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in normal human breast
25. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic breast disease
26. Gross cystic breast disease: Overview and directions for future research
27. The biochemistry of breast cyst fluids and duct secretions
28. Nonmalignant conditions of the breast
29. Steroid hormone receptors in benign breast disease
30. Circulating immune complexes in human breast cyst fluids: Relationship with intracystic irnmunoglobulin and electrolyte levels
31. Enzymatic levels in cystic fluid of breast macrocysts
32. The pattern of risk factors for breast cancer in a Southern France population. Interest for a stratified analysis by age at diagnosis
33. Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for existence of subpopulation of cysts
34. Cations and dehydroisoandrosterone-sulfate in human breast cyst fluid
35. Correlations between morphology, electrolytic content and risk factors in breast cysts
36. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast
37. Change in the glandular bodies of the breast after hormone therapy. Observations from the radiologic viewpoint
38. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme
39. Exogenous hormone use and fibrocystic breast disease by histopathologic component
40. Influence of endocrine history on the biochemical composition of breast cyst fluid